ESPRESSO STUDY

"Early Caffeine for Neuroprotection
in Preterm Neonates:
ESPRESSO STUDY"

Latest publications from our group:
PMID 29481811: behavioral testing in the rabbit
https://www.ncbi.nlm.nih.gov/pubmed/29481811


The 
Espresso study...
  1. A validated animal model will be used to study the pharmacokinetics of caffeine and its effects on neurological outcomes such as brain magnetic resonance imaging and behavioral tests.
  2. Subsequently the efficacy and safety of caffeine will be assessed in a clinical trial in very preterm infants.

Ċ
Matteo Bruschettini,
Mar 1, 2018, 5:13 AM
Ċ
Matteo Bruschettini,
Mar 1, 2018, 5:12 AM
Comments